New York Times Vs. Avidity Biosciences Industry Stock Comparison

Buy

62

NYT
New York Times

Last Price:

$55.28

Seasonality Move:

-0.97%

Sell

35

RNA
Avidity Biosciences

Last Price:

$29.93

Seasonality Move:

3.75%

Buy

62

New York Times (NYT) is a Buy

Is New York Times a Buy, Sell or Hold?

The current New York Times [NYT] share price is $55.29. The Score for NYT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
NYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

35

Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

The current Avidity Biosciences [RNA] share price is $29.90. The Score for RNA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is New York Times's stock price today?

The New York Times share price today is $55.29

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

The Avidity Biosciences share price today is $29.90

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NYT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.18	Buy
Relative Strength Index (14 RSI):	54.29	Buy
Chaikin Money Flow:	837549	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(54.69 - 56.23)	Sell
Bollinger Bands (100):	(48.24 - 54.66)	Buy

RNA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.38	Sell
Relative Strength Index (14 RSI):	45.19	Sell
Chaikin Money Flow:	620366	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(29.63 - 33.55)	Sell
Bollinger Bands (100):	(28.08 - 33.16)	Sell

NYT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.85	Buy
20-day SMA:	55.53	Sell
50-day SMA:	53.73	Buy
200-day SMA:	52.8	Buy
8-day EMA:	54.95	Buy
20-day EMA:	55.03	Buy
50-day EMA:	53.9	Buy
200-day EMA:	52.03	Buy

RNA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	29.76	Buy
20-day SMA:	31.79	Sell
50-day SMA:	30.51	Sell
200-day SMA:	35.23	Sell
8-day EMA:	30.12	Sell
20-day EMA:	30.84	Sell
50-day EMA:	30.79	Sell
200-day EMA:	32.13	Sell

New York Times Earnings Growth & NYT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.06 per share, an increase this year of $0.27 per share, and an increase next year of $0.20 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.10 per share, and a decrease next year of $0.50 per share.

New York Times Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20	Jun 23	Jun 24	Jun 25
	Jun
	11	12	13	16	17	18	20	23	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20	Jun 23	Jun 24	Jun 25
	Jun
	11	12	13	16	17	18	20	23	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):